Hey! It’s great to see you again. If you haven’t read it already, I highly encourage you to check out the first part of this article, where I discussed the basics of cancer, its epigenetic aspects, and how epigenetic editing methods can start a new era in cancer research.
In this article, I’ll break down one of the epigenetic editing tools mentioned in the previous article: CRISPR-dCas9. I’ll explain how it can be used to activate a tumor suppressor gene and discuss its potential significance in cancer research. Following that, I’ll share how I designed a CRISPR-dCas9 based on a research using Benchling’s tool. So, what are we waiting for?